ArticleBone marrow transplantation2013

Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.

P J A de Pagter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.